Bonnie L. Bassler - 08 Sep 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/** Bonnie L. Bassler
Issuer symbol
REGN
Transactions as of
08 Sep 2022
Net transactions value
-$999,689
Form type
4
Filing time
12 Sep 2022, 16:31:44 UTC
Previous filing
30 Jun 2022
Next filing
30 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $501,266 +1,279 +118% $391.92 2,361 08 Sep 2022 Direct F1
transaction REGN Common Stock Sale $901,695 -1,279 -54% $705.00 1,082 08 Sep 2022 Direct F1, F2
transaction REGN Common Stock Options Exercise $501,266 +1,279 +118% $391.92 2,361 08 Sep 2022 Direct F1
transaction REGN Common Stock Sale $878,660 -1,279 -54% $686.99 1,082 08 Sep 2022 Direct F1
transaction REGN Common Stock Options Exercise $229,404 +609 +56% $376.69 1,691 09 Sep 2022 Direct F1
transaction REGN Common Stock Sale $451,269 -609 -36% $741.00 1,082 09 Sep 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -609 -50% $0.000000 610 09 Sep 2022 Common Stock 609 $376.69 Direct F1, F3
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,279 -25% $0.000000 3,839 08 Sep 2022 Common Stock 1,279 $391.92 Direct F1, F3
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,279 -33% $0.000000 2,560 08 Sep 2022 Common Stock 1,279 $391.92 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 1,279 shares of Company stock on September 8, 2022 at prices ranging from $705.00 to $705.06. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 8, 2022 at each separate price.
F3 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.